[Retracted] Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Table 1

Basic clinical features of 14 literatures were included in our study.

Study	Age	Gender (man)	Hospitalization days	Experimental group ()	Control group ()	NOS score	Research type
Reck M [11]		42.25%		200/305	105/305	7	RCT
Garon EB [12]		68.12%		315/495	278/495	7	RCT
Reck M [13]		46.72%		167/305	158/305	8	RCT
Goldberg SB [14]		45.12%		33/52	28/52	7	RCT
Eichhorn F [15]		51.89%		21/30	15/30	8	RCT
Amrane K [16]		63.45%		67/108	54/108	7	RCT
Jabbour SK [17]		68.10%		12/21	9/21	7	RCT
Middleton G [18]		49.75%		78/112	56/112	7	RCT
Herbst RS [19]		59.23%		51/92	41/92	7	RCT
Lisberg A [20]		57.22%		14/25	11/25	8	RCT
Eichhorn F [21]		54.16%		10/15	5/15	7	RCT
Hellmann MD [22]		67.34%		322/601	255/601	7	RCT
Weiss GJ [23]		49.34%		39/49	28/49	9	RCT
Hui R [24]		54.12%		68/101	56/101	8	RCT